Clinical trials
Prostatic Hyperplasia trials in the United States with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
62 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 3 |
| 2011 | 1 |
| 2013 | 5 |
| 2014 | 4 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 6 |
| 2018 | 2 |
| 2020 | 4 |
| 2021 | 4 |
| 2022 | 9 |
| 2024 | 7 |
| 2025 | 4 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 22 |
| Recruiting | 13 |
| Active, not recruiting | 10 |
| Terminated | 5 |
| Unknown status | 5 |
| Withdrawn | 4 |
| Not yet recruiting | 1 |
| Enrolling by invitation | 1 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Northwestern University | 7 |
| NeoTract, Inc. | 4 |
| PROCEPT BioRobotics | 3 |
| Northwell Health | 2 |
| ProVerum Medical | 2 |
| University of California, San Francisco | 2 |
| University of Kansas Medical Center | 2 |
| University of North Carolina, Chapel Hill | 2 |
| Urotronic Inc. | 2 |
| ALPFA Medical | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prostatic Hyperplasia | 62 |
| Lower Urinary Tract Symptoms | 21 |
| Prostatic Neoplasms | 4 |
| Hyperplasia | 3 |
| Nocturia | 3 |
| Urinary Incontinence | 3 |
| Diabetes Mellitus | 2 |
| Male Urogenital Diseases | 2 |
| Prostatism | 2 |
| Urinary Bladder, Overactive | 2 |
Trials
Showing 1 to 25 of 62. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.